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Abstract
Observational studies suggest that breast-feeding is associated with a more favourable BMI and cardio-metabolic markers, but potential
underlying mechanisms are unclear. As serum adiponectin has an important function in adults for glucose and lipid metabolism, we assessed 251
participants of the Prevention and Incidence of Asthma and Mite Allergy birth cohort whether breast milk adiponectin is associated with
childhood BMI and cardio-metabolic markers. We measured adiponectin levels in breast milk collected around 3 months after birth of the child
and subsequently obtained weight and height repeatedly up to the age of 17 years. A medical examination (including blood pressure, glycated
Hb and cholesterol) was performed at the age of 8, 12 and 16 years. We used multivariable mixed models to assess the association between
breast milk adiponectin and BMI and cardio-metabolic markers at these ages. In models adjusted for exact age of breast milk collection, maternal
age, presence of siblings, maternal BMI, pregnancy weight gain and child’s birth weight, each unit increase in log breast milk adiponectin (in ng/
ml) was associated with a 0·28 lower BMI z score (95% CI –0·56, 0·00) at 3 months. After the age of 1 year, there was a tendency towards a higher
BMI z score with increased breast milk adiponectin at some ages, but this pattern was not consistent throughout childhood. There were no
associations between breast milk adiponectin and any of the cardio-metabolic markers in childhood. We conclude that in our study with follow-
up until 17 years of age, breast milk adiponectin has no long-term effect on BMI and cardio-metabolic health during childhood.
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Adiponectin is an adipokine involved in several biological
processes in the human body and generally known for its anti-
atherogenic and anti-inflammatory effects(1). A higher serum
adiponectin level is associated with lower CVD(1). Remarkably
for an adipokine, it is down-regulated in obese subjects(2).
Adiponectin was discovered to be present in breast milk in
2006(3). Obviously, breast milk is important for growth and
development of the infant. Infant growth is subsequently asso-
ciated with later growth and overweight(4,5). Breast milk compo-
sition, including adiponectin levels, varies between mothers(6). It
is therefore of interest whether these different adiponectin levels
in breast milk are associated with infant growth. Earlier epide-
miological studies suggested that higher breast milk adiponectin is
associated with a lower weight gain in the first 4–6 months of
life(7,8) and with a higher weight gain thereafter(7,9). This resulted
in a higher weight for length(9) or increased overweight pre-
valence(10) at the age of 2 years. Regarding the latter, it is hypo-
thesised that this may be the result of a delayed catch-up growth
after the period of active breast-feeding. It is relevant to know
whether the higher weight or weight gain after the first year of life
associated with adiponectin persists in later childhood as tracking
of overweight from childhood to adulthood becomes stronger
from the age of 2 years onwards(11). However, little is known
about breast milk adiponectin and the development of over-
weight up to adolescence, apart from one study reporting follow-
up up to the age of 5 years(12).
Breast milk is also associated with long-term health effects(13).
This may be because the first period of life is characterised by a
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high plasticity, where early exposures can permanently change
the function and structure of organs(14). The association
between breast milk adiponectin and cardio-metabolic markers
has not been reported so far, while we hypothesise that such an
association may be plausible, given the role of adiponectin in
glucose and lipid metabolism(6,15,16).
In this study, with follow-up until the age of 17 years, we aim
to extend the findings from earlier studies and assess whether
breast milk adiponectin is associated with lower BMI in the first
year of life but with higher BMI thereafter. In addition, we study
associations between breast milk adiponectin and cardio-
metabolic markers (cholesterol, glycated Hb and blood pres-
sure) throughout childhood.
Methods
Study design, setting and study population
We used the data from a population-based Dutch birth cohort
study: the Prevention and Incidence of Asthma and Mite Allergy
(PIAMA) Study. Details of the study are described else-
where(17,18). In short, pregnant women were recruited from the
general population during their first antenatal visit. Their chil-
dren (n 3963) were born in 1996/1997. Data were collected by
questionnaires; one in the third trimester of pregnancy, and
postnatally at the age of 3 months, yearly around the child’s
birthday from age 1 year until the age of 8 years, and thereafter
at the ages of 11, 14 and 17 years. In addition, in a subgroup of
children, a home visit was performed around the age of
3 months, and extensive medical examinations were performed
at the ages of 4, 8, 12 and 16 years. Eligible for the present study
were all children from mothers who were still breast-feeding
during the home visit around the age of 3 months and were
willing and able to produce a breast milk sample. The total
study population for analysis consisted of 251 children (223
after excluding missing values on the covariates) (Fig. 1). This
study was conducted according to the guidelines laid down in
the Declaration of Helsinki, and all procedures involving
human subjects were approved by the medical ethics commit-
tees of the participating institutes. All parents gave written
informed consent.
Outcomes: anthropometrics and cardio-metabolic markers
in childhood
In each questionnaire, parents were asked to report child’s
weight and height measured by a medical professional during
the regular scheduled visits to a youth health centre if this
measurement was within the last 3 months. Otherwise parents
were asked to measure their child’s weight and height them-
selves without shoes and heavy clothes. Regarding the
anthropometrics, BMI was our primary interest as it is an indi-
cator of overweight. BMI was calculated as weight (kg)/height2 (m),
and age- and sex-specific z scores were calculated according to
national reference curves(19). To be able to understand the
responsible component of an attained BMI value, we also
assessed the weight-for-age z scores, length/height-for-age z
scores, and weight-for-length/height z scores as well as weight
gain during the first year of life. Weight gain during the first year
of life was defined as the difference in absolute weight in
kilogram per month between birth and 3 months and between 3
and 12 months. We also obtained measured weight and height
at the age of 4, 8, 12 and 16 years of age, during the follow-up
visits, which were standardised and taken by a trained field
worker. The cardio-metabolic markers were measured at the
age of 8, 12 and 16 years. Serum total and HDL-cholesterol were
determined (Roche Diagnostics). Intra-assay variation was 0·8%
for total cholesterol (n 63), and 0·95% for HDL (n 21). HbA1c
was measured using the Adams A1c, HA-8160 HPLC Auto
analyser (Menarini Diagnostics Benelux). Blood pressure
readings were obtained at age 12 and 16 years using an Omron
M6 Monitor. Two blood pressure measurements were taken at
5min intervals. If two consecutive measures differed by
>5mmHg, another measurement was taken. The mean of (2 or
3) systolic and diastolic measurements was used in analyses.
Exposure: breast milk adiponectin
Details of human milk collection have been reported else-
where(20). In short, mothers were asked to provide two samples
of about 2ml each. There were no restrictions regarding the type
of collection (though the mothers were asked to avoid fore or
hind milk), method of collection (manual expression or breast
pump) or time, but these characteristics were documented. The
milk samples were collected between 2 and 35 weeks after birth,
but the majority of the breast milk samples (77%) were obtained
between 11 and 18 weeks of delivery. The samples were put into
tubes containing 2 µl butylated hydroxyl toluene solution
(500 µg/ml) to prevent oxidation. Mothers were asked to send
the samples immediately after collection to the National Institute
of Public Health and the Environment, so the samples could be
stored within 1 d at −70°C until analysis.
Assay
For breast milk adiponectin analyses, breast milk was cen-
trifuged (15min, 21 000g at 4°C). The fatty layer was discarded.
Adiponectin was determined using the adiponectin (human)
radioimmunoassay #HADP-61HK (EMD Millipore Corporation).
Lower limit of detection was 0·8 ng/ml. Inter-assay variation was
<5·5% in the range of 10–70 ng/ml (n 10).
Covariates
Maternal pre-pregnancy weight and height were self-reported
when the child is of 1 year. Birth weight and gestational age
were obtained by questionnaire at 3 months after birth. In these
first year questionnaires, also other characteristics were
obtained such as maternal education, method of delivery and
maternal smoking. At the child’s age of 3 months, parents
received a form on which they kept records of their child’s age
in weeks when complementary foods were introduced for the
first time. On the same form, parents indicated the child’s age in
weeks when breast-feeding was ended and when formula
feeding was initiated. The form was returned to the study centre
around the child’s first birthday.
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We compared baseline characteristics of mothers and children
between tertiles of breast milk adiponectin levels. We com-
pared percentages and absolute numbers for categorical vari-
ables and tested differences with the χ2 test. We compared
means (SD) for continuous variables and tested differences with
ANOVA. To assess the association between breast milk adipo-
nectin and the outcome variables (BMI z score, weight-for-age
z score, length/height-for-age z score and weight-for-length/
height z score and cardio-metabolic markers), we performed a
multivariable mixed model analysis including a random inter-
cept with breast milk adiponectin as the independent variable
and BMI z score (continuous) as the dependent variable. The
mixed model takes into account the correlation between the
BMI z score within each child over time. To obtain age-specific
estimates of the association, we added an interaction term for
the exposure with age (in years) as a categorical variable. We
applied a log transformation to obtain a normal distribution for
adiponectin. We checked for non-linear association using
penalised splines in R version 2.10.0. No departure for linearity
was observed, and therefore we treated breast milk adiponectin
as a continuous variable. Thus, the regression coefficient
reflects the increase in BMI z score for each unit increase in log
adiponectin (in ng/ml). We adjusted for exact age of breast milk
measurement to reduce misclassification of exposure. We
identified potential confounders by a combination of a priori
considerations and literature(3,6,10,21). We considered maternal
age, presence of older siblings, maternal pre-pregnancy BMI,
gestational weight gain and birth weight as potential con-
founders and included these in the adjusted models for BMI
z score. To assess the association between adiponectin and
weight gain per month during the first year of life, we per-
formed multivariable linear regression analyses. These models
were additionally adjusted for child’s sex and exact age at
weight measurement. We performed sensitivity analyses. First,
to take into account breast-feeding duration, we (a) repeated
the analysis with an interaction term for adiponectin× breast-
feeding duration and (b) restricted the analyses to those chil-
dren who were exclusively breast-fed during the first 3 months
of life for the analysis of weight gain per month between birth
and 3 months. Second, we repeated the analysis with the
anthropometrics measured by the investigators instead of
parental-measured and -reported anthropometrics.
Results
The 251 mothers in this study had slightly higher gestational
age, higher age and higher BMI compared with remaining
PIAMA participants. They also had more often a higher edu-
cation and smoked less often (Table 1).
Mean breast milk adiponectin level was 15·3 (SD 11·9) ng/ml.
Mean maternal age at birth was 30·9 (SD 3·9) years, with a pre-
pregnancy BMI of 22·3 (SD 3·1) kg/m2. Birth weight of the child
was 3540 (SD 493) g and gestational age was 40·1 (SD 1·4) weeks.
Although none of the differences were statistically significant,
mothers with breast milk adiponectin in the lowest tertile were
slightly older, were less often primiparous and had in general
less favourable indicators (i.e. higher BMI, more smoking and
gain more often excessive weight). Their children had a slightly
higher birth weight (Table 2).
There were no association of breast milk adiponectin with
child’s age at breast milk collection, sampling time and sam-
pling method (manual, pump, foremilk, hind milk, full milk)
(data not shown).
At the age of 3 months, each unit increase in log adiponectin
(ng/ml) was associated with a 0·30 (95% CI –0·57, –0·04) lower
BMI z score in crude analysis (Table 3). After adjustment, the
association attenuated to a 0·28 (95% CI –0·56, 0·00) lower BMI
PIAMA population at birth
n 3963
Home visit (age 3 months)
n 1860
Mothers delivering a breast
milk sample
n 276
Baseline population n 251
Population for analyses n 223
At age 8 years:
Blood lipids: n 124
HbA1c: n 122
Blood pressure: not measured
At age 12 years:
Blood lipids: n 115
HbA1c: n 112
Blood pressure: n 126
At age 16 years:
Blood lipids: n 59
HbA1c: n 58
Blood pressure: n 62
Not invited n 2103
No breastfeeding n 1199
Not willing to sample n 385
Insufficient material  n 21
Outlier (> 200 ng/ml) n 2
Loss-to-follow-up  n 2
Missing on covariates n 28
Not invited n 73
Fig. 1. Flow chart from baseline population to population for analyses and number of children for each cardio-metabolic outcome. PIAMA, Prevention and Incidence of
Asthma and Mite Allergy.
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z score. From the age of 1 year onwards, children receiving
breast milk with a higher level of adiponectin tended to have a
higher BMI z score, but this was not consistent throughout
childhood, and statistically significant at the age of 4 years only
(Table 3). Associations were similar for weight-for-length/height
z score (online Supplementary Table S1). Analyses that inclu-
ded an additional term for adiponectin× breast-feeding dura-
tion showed similar associations (data not shown).
Children receiving breast milk with higher levels of adipo-
nectin tended to have a lower weight-for-age z score and a
lower length/height-for-age z score, except between 2 and
4 years of age (Table 4). At the age of 3 months, the effect
estimate for weight-for-age z score was larger than for length/
height-for-age z score. This reversed after the age of 1 year,
where the effect estimate for length/height-for-age z score was
larger than for weight-for-age z score.
Each unit increase in log breast milk adiponectin (ng/ml) was
associated with a 0·11kg/month (95% CI –0·17, –0·05) lower
weight gain during the first 3 months of life, while each unit
increase in log adiponectin was associated with a 0·02kg/month
(95% CI –0·00, 0·04) change in weight gain between 3 and
12 months after birth. Estimates for weight gain in the first 3 months
were similar when the analyses were restricted to exclusively
breast-fed children (70% of the study population, data not shown).
No statistically significant associations were observed
between breast milk adiponectin and level of serum lipids,
HbA1c or blood pressure at the age of 8, 12 and 16 years
(Table 5).
We repeated the analysis for age 4, 8, 12 and 16 years with
measured anthropometrics instead of parental measured and
-reported anthropometrics, and the associations were similar
(Tables 3 and 4 and online Supplementary Table S1).
Table 1. Comparison Prevention and Incidence of Asthma and Mite Allergy (PIAMA) of participants who had adiponectin measured
compared with PIAMA participants with no data on adiponectin
(Mean values and standard deviations for continuous variables; numbers and percentages for categorical variables)
Adiponectin sample (n 251) No adiponectin sample (n 3712)
Mean SD Mean SD P*
Maternal characteristics
































Gestational age (weeks) 40·1 1·4 39·8 1·7 0·003
Birth weight (g) 3540 492 3505 550 0·33
Breast milk characteristics
Mean breast-feeding duration (weeks)
Any breast-feeding‡ 29·9 12·5 13·9 14·6 <0·0001
Exclusive breast-feeding 21·4 13·5 11·2 13·3 <0·0001
* P value for χ2 test for categorical variables, and for t test for continuous variables.
† According to the criteria of the Institute of Medicine 2009.
‡ Any amount of breast-feeding, irrespective of the amount of mixed feeding with infant formula.
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Table 2. Baseline characteristics of Prevention and Incidence of Asthma and Mite Allergy participants, total and stratified for tertiles of breast milk adiponectin (n 251)*
(Mean values and standard deviations for continuous variables; numbers and percentages for categorical variables)
Total Lowest tertile Middle tertile Highest tertile
n Mean SD Mean SD Mean SD Mean SD P*
Maternal characteristics
Maternal age (years) 250 30·9 3·9 31·6 3·5 30·8 3·6 30·4 4·4 0·12
Maternal education 247 0·63
Low
n 32 14 9 9
% 13·0 17·1 11·0 10·8
Middle
n 100 29 34 37
% 40·4 35·4 41·5 44·6
High
n 115 39 39 37
% 46·6 47·6 47·6 44·6
Maternal pre-pregnancy BMI (kg/m2) 230 22·3 3·1 22·7 3·3 22·1 2·7 22·2 3·3 0·55
Maternal smoking 249 0·88
n 27 10 9 8
% 10·8 12·1 10·8 9·6
First child 251 0·07
n 134 37 44 53
% 53·4 44·6 53·0 62·4
Perinatal characteristics
Gestational weight gain† 225 0·26
Inadequate
n 65 20 19 26
% 28·9 26·7 25·3 34·7
Adequate
n 93 29 38 26
% 41·3 38·7 50·7 34·7
Excessive
n 67 26 18 23
% 29·8 34·7 24·0 30·7
Caesarean section 250 0·94
n 19 6 7 6
% 7·6 7·3 8·4 7·1
Gestational age (weeks) 251 40·1 1·4 40·2 1·3 40·0 1·4 40·2 1·5 0·79
Birth weight (g) 251 3540 493 3577 481 3553 520 3489 477 0·48
Breast milk characteristics
Breast milk adiponectin (ng/ml) 251 15·3 11·9 8·5 1·7 12·8 1·4 24·4 16·7 <0·0001
Timing of breast milk collection in days after birth 248 107 28 108 32 106 22 109 30 0·78
Mean breast-feeding duration (weeks)
Any breast-feeding‡ 251 30·0 12·5 31·7 13·0 27·4 11·4 30·7 12·7 0·07
Exclusive breast-feeding 220 21·4 13·5 23·0 14·3 19·8 12·6 21·3 13·3 0·37
* P value for χ2 test for categorical variables, and for ANOVA for continuous variables.
† According to the criteria of the Institute of Medicine 2009.
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Discussion
A relative high content of adiponectin in breast milk was asso-
ciated with a lower BMI z score and lower weight-for-age
z score at the age of 3 months, and a lower weight gain between
birth and 3 months of age. Between the age of 1 and 17 years,
children exposed to a relatively high content of adiponectin in
breast milk tended to be lighter for their age as well as shorter
for their age as compared with children exposed to a low breast
milk adiponectin content. The combination of relatively low
weight-for-age and relatively low length/height-for-age z scores
resulted in BMI values that were neither consistently lower nor
consistently higher in the children with a relatively high content
of adiponectin in breast milk. Breast milk adiponectin was not
associated with cardio-metabolic markers in childhood.
Methodological considerations
The large number of repeated measurements of weight and
height during childhood allowed us to provide a detailed pic-
ture of the development of the potential association up to
adolescence. We were also able to assess potential confounding
due to characteristics that have been described in the literature
to affect breast milk adiponectin, including maternal overweight
and method of delivery(22). However, some limitations should
be addressed. Some misclassification of breast milk adiponectin
levels may be present since we collected only one sample of
breast milk from the study, and milk collection was not strictly
standardised according to the time of the day or fore or hind
milk to decrease the burden on the participants. Although we
have information on breast-feeding duration and exclusivity, we
Table 3. Association between breast milk adiponectin and BMI z score throughout childhood, at different ages†
Crude change in BMI z score/ng per ml increase in log
adiponectin (n 251)
Adjusted change in BMI z score/ng per ml increase in log adiponectin
(95% CI) (n 223)
Age Self-reported Measured Self-reported Measured
3 months –0·30* –0·57, –0·04 NA –0·28 –0·56, 0·00 NA
1 year –0·02 –0·25, 0·21 NA 0·10 –0·17, 0·37 NA
2 years –0·04 –0·30, 0·22 NA 0·11 –0·17, 0·38 NA
3 years –0·02 –0·24, 0·20 NA 0·07 –0·17, 0·31 NA
4 years 0·19 –0·04, 0·41 0·08 –0·13, 0·30 0·25* 0·01, 0·49 0·21 –0·03, 0·45
5 years –0·23 –0·47, 0·02 NA –0·13 –0·39, 0·12 NA
6 years 0·11 –0·12, 0·33 NA 0·18 –0·04, 0·40 NA
7 years –0·03 –0·32, 0·25 NA 0·01 –0·28, 0·30 NA
8 years –0·21 –0·58, 0·16 0·01 –0·19, 0·21 –0·15 –0·53, 0·23 0·10 –0·09, 0·30
11/12 years –0·16 –0·44, 0·11 –0·06 –0·38, 0·26 –0·12 –0·39, 0·15 0·02 –0·30, 0·33
14 years –0·13 –0·44, 0·19 NA –0·08 –0·39, 0·23 NA
16/17 years 0·09 –0·27, 0·45 –0·03 –0·68, 0·63 0·12 –0·26, 0·50 –0·02 –0·70, 0·66
Overall estimate –0·06 –0·23, 0·11 0·02 –0·18, 0·23 0·09 –0·17, 0·19 0·11 –0·10, 0·32
NA, not applicable.
* P<0·05.
† Association was adjusted for exact age of breast milk collection, maternal age, presence of siblings, maternal BMI, pregnancy weight gain and child’s birth weight. Correlation
between repeated measurements within the same children were taken into account with mixed models. The number of observations at each specific age for self-reported BMI
z from 3 months to 17 years were 188, 213, 205, 214, 193, 173, 175, 161, 164, 153, 149, 120, respectively.
Table 4. Association between breast milk adiponectin and weight-for-age and length/height-for age z score throughout childhood, at different ages†
Age
Crude change in weight-for-
age z score/ng per ml
increase in log adiponectin
Adjusted change in weight-
for-age z score/ng per ml
increase in log adiponectin
Crude change in length/
height-for-age z score/ng per
ml increase in log adiponectin
Adjusted change in length/
height-for-age z score/ng per
ml increase in log adiponectin
3 months –0·38** –0·66, –0·11 –0·38** –0·62, –0·15 –0·17 –0·47, 0·12 –0·19 –0·45, 0·07
1 year –0·10 –0·32, 0·12 –0·08 –0·29, 0·13 –0·13 –0·42, 0·15 –0·24 –0·50, 0·03
2 years 0·08 –0·16, 0·32 0·14 –0·08, 0·36 0·15 –0·16, 0·45 0·08 –0·21, 0·38
3 years 0·05 –0·19, 0·29 0·08 –0·16, 0·31 0·09 –0·20, 0·37 0·03 –0·26, 0·32
4 years 0·07 –0·18, 0·32 0·09 –0·15, 0·32 –0·11 –0·41, 0·18 –0·15 –0·43, 0·13
4 years measured 0·04 –0·20, 0·28 0·10 –0·13, 0·34 –0·03 –0·28, 0·22 –0·08 –0·32, 0·16
5 years –0·20 –0·43, 0·03 –0·19 –0·39, 0·02 –0·16 –0·44, 0·11 –0·22 –0·47, 0·03
6 years –0·05 –0·27, 0·17 –0·02 –0·22, 0·17 –0·20 –0·48, 0·07 –0·24 –0·51, 0·03
7 years –0·13 –0·36, 0·09 –0·12 –0·33, 0·08 –0·18 –0·44, 0·07 –0·23 –0·47, 0·01
8 years –0·23 –0·49, 0·03 –0·23 –0·47, 0·02 –0·18 –0·44, 0·08 –0·25 –0·50, 0·00
8 years measured –0·11 –0·33, 0·11 –0·08 –0·28, 0·12 –0·21 –0·46, 0·04 –0·26 –0·50, –0·03
11 years –0·25* –0·49, –0·02 –0·25* –0·46, –0·03 –0·35* –0·62, –0·08 –0·40** –0·65, –0·14
12 years measured –0·17 –0·44, 0·11 –0·13 –0·40, 0·13 –0·29 –0·54, –0·04 –0·35 –0·60, –0·09
14 years –0·14 –0·41, 0·14 –0·17 –0·43, 0·08 –0·26 –0·53, 0·00 –0·32 –0·59, –0·05
16 years measured –0·08 –0·53, 0·37 –0·10 –0·53, 0·33 –0·28 –0·66, 0·09 –0·32 –0·70, 0·05
17 years 0·02 –0·25, 0·30 0·00 –0·28, 0·28 –0·17 –0·47, 0·13 –0·24 –0·53, 0·06
Overall estimate –0·11 –0·31, 0·08 –0·10 –0·28, 0·13 –0·13 –0·37, 0·10 –0·19 –0·41, 0·02
Overall estimate measured –0·06 –0·29, 0·17 –0·04 –0·24, 0·17 –0·16 –0·40, 0·07 –0·23 –0·45, –0·00
* P<0·05; ** P<0·01.
† Associations were adjusted for exact age of breast milk collection, maternal age, presence of siblings, maternal BMI, pregnancy weight gain and child’s birth weight. Correlation
between repeated measurements within the same children were taken into account with mixed models.










roningen , on 27 M
ar 2019 at 07:09:41 , subject to the Cam
bridge Core term






do not know the overall breast milk volume and therefore lack
information on the total amount of exposure to adiponectin in
the breast-feeding period. It is likely that other hormones such as
leptin and insulin are important for body composition as well. It
was not possible to analyse these hormones in our samples, and
therefore our inference is restricted to solely one metabolite.
Although weight and length/height were measured during the
medical examinations at age 4, 8, 12 and 16 years, we used the
weight and length/height obtained by the questionnaires,
because of the higher frequency of these data in the early years.
We reported on the validity of self-reported v. measured height
and weight and concluded that BMI measured and reported by
the parents is a valid alternative for observed BMI(23,24). Although
loss to follow-up was present in our study, it would only lead to
bias if children exposed to a low or high breast milk adiponectin
level and a specific growth trajectory would be more often lost to
follow up. It is unlikely that this has occurred. However, the
smaller number of observations in older children have affected
the precision of our estimates, resulting in wider confidence
intervals around the estimates. Lastly, we do not have informa-
tion on maternal BMI at the exact moment of breast milk sam-
pling. Therefore, we used maternal pre-pregnancy BMI as a
proxy. This may have resulted in some misclassification.
Underlying mechanism
The correlation between maternal serum adiponectin and
breast milk adiponectin suggests that mammary epithelial cells
have a role in secreting adiponectin in breast milk, either by
new synthesis or by transferring it from maternal serum(25). In
addition, it is fully absorbed by the infant’s digestive tract,
making a biological function plausible(6,22). This biological
function may be related to weight gain as higher adiponectin
content of breast milk was suggested to decrease gastric
emptying in fully breast-fed infants(26). Gastric emptying rate is
associated with satiety, which in turn influences growth via
energy intake. Although we did not observe a clear and con-
sistent long-term effect of breast milk adiponectin on BMI in
later childhood, this single observation does not rule out that
breast milk adiponectin may be an important hormone for
long-term health. It was hypothesised that breast milk adipo-
nectin only expresses its function during the period of active
breast-feeding. After stopping breast-feeding, there may be a
delayed ‘catch-up growth’. As opposed to early catch-up
growth, later ‘catch-up growth’ may result in relatively more
lean mass than fat mass(9). Indeed, we observed lower weight
gain during the first 3 months, which was not observed
between 3 months and 1 year, the period where most mothers
stop breast-feeding. This biological path should be further
explored. It would be interesting to elucidate the potential link
between pregnancy adiponectin levels and breast milk adi-
ponectin(25,27,28), as we noticed differences in birth weight
between the children born to mothers in the different breast
milk adiponectin tertiles. Although we adjusted for birth
weight in the analyses, we do not exclude the possibility that
maternal exposures during pregnancy influence birth weight
as well as breast milk adiponectin. Future studies can shed
more light on the interactions between maternal adiponectin
Table 5. Association between breast milk adiponectin and cardio-metabolic markers at age 8, 12 and 16 years*
Outcome n
Change in each unit of the cardio-metabolic
marker/ng per ml increase in log adiponectin 95% CI
Blood lipids (mmol)
Total cholesterol (mmol)
Age 8 years 124 0·05 –0·16, 0·25
Age 12 years 115 –0·14 –0·33, 0·06
Age 16 years 59 0·13 –0·25, 0·51
Overall estimate –0·02 –0·21, 0,17
HDL (mmol)
Age 8 years 124 0·05 –0·06, 0·17
Age 12 years 115 –0·05 –0·14, 0·05
Age 16 years 59 0·10 –0·06, 0·26
Overall estimate 0·02 –0·07, 0·11
TAG (mmol)
Age 16 years 59 –0·30 –0·68, 0·08
HbA1c (%)
Age 8 years 122 –0·09 –0·21, 0·05
Age 12 years 112 0·04 –0·05, 0·13
Age 16 years 58 0·85 –0·53, 2·23
Overall estimate 0·60 –1·49, 2·69
Blood pressure (mmHg)
Systolic (mmHg)
Age 12 years 126 2·38 –0·73, 5·48
Age 16 years 62 1·17 –4·18, 6·51
Overall estimate 2·13 –0·64, 4·89
Diastolic (mmHg)
Age 12 years 126 0·65 –1·51, 2·81
Age 16 years 62 –0·81 –4·02, 2·40
Overall estimate 0·37 –1·77, 2·51
* Correlation between repeated measurements within the same children was taken into account with mixed models.
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level during pregnancy, breast milk adiponectin and child-
hood serum adiponectin in relation to anthropometry in
childhood. For now, despite its potential importance of reg-
ulating infancy growth, adiponectin seems not to be a target
component for optimising infant feeding and prevent child-
hood overweight.
Comparison with earlier studies
Breast milk adiponectin levels were comparable with con-
centrations found in earlier studies(3,7–10,29–32). Some differences
in adiponectin levels may be explained by differences in
maternal characteristics. It was reported that breast milk adi-
ponectin levels were associated with maternal factors such as
BMI, ethnicity and lactation duration(3,30).
Our finding that high breast milk adiponectin is associated
with lower BMI z score and weight-for-age at age 3 months is
comparable with earlier studies that have reported about breast
milk adiponectin and infant weight-for-length and weight-for-
age in the first year of life(8,31). Also, the lower weight gain in
the first 3 months of life has been reported before(7).
Earlier studies about BMI development after this first year are
inconsistent. Some studies reported that the association
reversed after the first year of life, with increasing weight-for-
age and weight-for-length z scores until the age of 2 years(9) or
higher overweight risk at the age of 2 years(10) with higher
adiponectin levels. However, one follow-up study did not
report an association between adiponectin and weight, BMI or
fat mass after the age of 3 years(12). The lower height-for-age z
score in our results was not reported earlier(9), and we have no
explanation for this. We extend previous findings by reporting
that children who received breast milk with a relatively high
content of breast milk adiponectin tended to have lower
weight-for-age and height-for-age between the age of 1 and 17
years, which resulted in no consistent association with BMI in
childhood. Future studies have to confirm our findings and
would ideally include repeated serum measurements of adi-
ponectin as well as measurements of body fat.
To our knowledge, there are no previous studies to com-
pare our results with regarding the cardio-metabolic markers.
Adiponectin increases insulin sensitivity. Earlier studies
showed that serum adiponectin in childhood is associated
with measures of insulin and glucose(33). It has been sug-
gested that serum adiponectin may serve as a biomarker for
the metabolic syndrome. Similar to the BMI outcomes, breast
milk adiponectin may therefore only have an immediate effect
on cardio-metabolic indicators but does not exert a pro-
gramming and thus long-term effect on glucose and lipid
metabolism, which may explain that we did not find an
association between breast milk adiponectin and later cardio-
metabolic markers.
Conclusion
A higher content of adiponectin in breast milk is associated with
lower BMI and lower weight gain in early infancy, but we
observed no long-term effect of breast milk adiponectin on BMI
or cardio-metabolic markers after the age of 1 year up to the
age of 17 years.
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